Insider trading

Period: 120 months Stock: CRNX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

150 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

150 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

150 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

150 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
150 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
150 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

150 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jul 2026
Sold on a plan
$120.00K 3,000 at 40.00
13.5%
Planned (10b5-1)
17 Jun 2026
Okey Stephanie Director
Sold on a plan 2×
$246.14K 6,900 at 35.67
51.9%
Sold half or more
8 Apr 2026
Knight Jeff E. Chief Dev. & Operating Officer
Sold on a plan
$3.42M 85,163 at 40.10
44.7%
Planned (10b5-1)
16 Mar 2026
Struthers Richard Scott President & CEO
Sold on a plan 2×
$821.51K 21,981 at 37.37
5.2%
Planned (10b5-1)
16 Mar 2026
Betz Stephen F. Chief Scientific Officer
Sold on a plan 2×
$396.61K 10,612 at 37.37
7.2%
Planned (10b5-1)
16 Mar 2026
Knight Jeff E. Chief Operating Officer
Sold on a plan 2×
$370.41K 9,911 at 37.37
8.1%
Planned (10b5-1)
12 Mar 2026
Sold on a plan 2×
$180.76K 5,000 at 36.15
23.5%
Planned (10b5-1)
3 Mar 2026
Schilke Tobin Chief Financial Officer
Sold on a plan
$266.30K 6,713 at 39.67
7.9%
Planned (10b5-1)
3 Mar 2026
Okey Stephanie Director
Sold on a plan
$119.01K 3,000 at 39.67
18.4%
Planned (10b5-1)
5 Jan 2026
Kalofonos Isabel Chief Commercial Officer
Sold on a plan
$137.50K 2,500 at 55.00
75.0%
Sold half or more
1 Dec 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$225.10K 5,000 at 45.02
7.0%
Planned (10b5-1)
3 Nov 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan 2×
$213.31K 5,000 at 42.66
7.0%
Planned (10b5-1)
1 Oct 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$209.05K 5,000 at 41.81
7.0%
Planned (10b5-1)
26 Sep 2025
Fust Matthew K Director
Sold on a plan
$716.00K 16,000 at 44.75
41.2%
Planned (10b5-1)
26 Sep 2025
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$180.00K 4,000 at 45.00
3.6%
Planned (10b5-1)
2 Sep 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$160.50K 5,000 at 32.10
4.9%
Planned (10b5-1)
22 Aug 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$912.90K 30,000 at 30.43
31.2%
Planned (10b5-1)
20 Aug 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$189.44K 6,492 at 29.18
8.9%
Planned (10b5-1)
12 Jun 2025
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$3.14M 97,483 at 32.23
49.4%
Planned (10b5-1)
19 Mar 2025
Struthers Richard Scott President & CEO
Sold on a plan 2×
$593.02K 17,338 at 34.20
5.0%
Planned (10b5-1)
19 Mar 2025
Knight Jeff E. Chief Operating Officer
Sold on a plan 2×
$244.96K 7,162 at 34.20
7.6%
Planned (10b5-1)
19 Mar 2025
Betz Stephen F. Chief Scientific Officer
Sold on a plan 2×
$197.35K 5,770 at 34.20
5.0%
Planned (10b5-1)
19 Mar 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan 2×
$86.02K 2,515 at 34.20
3.4%
Planned (10b5-1)
3 Feb 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$195.35K 5,000 at 39.07
13.6%
Planned (10b5-1)
3 Jan 2025
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$781.35K 15,000 at 52.09
33.9%
Planned (10b5-1)
2 Dec 2024
Struthers Richard Scott President & CEO · indirect
Sold on a plan
$575.70K 10,000 at 57.57
9.1%
Planned (10b5-1)
22 Nov 2024
Knight Jeff E. Chief Operating Officer
Sold on a plan
$28.32K 501 at 56.52
1.0%
Planned (10b5-1)
3 Oct 2024
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$785.31K 14,375 at 54.63
33.5%
Planned (10b5-1)
26 Sep 2024
Sold on a plan
$1.28M 25,000 at 51.11
18.4%
Planned (10b5-1)
10 Sep 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$53.30K 1,035 at 51.50
1.5%
Planned (10b5-1)
26 Aug 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$159.57K 3,000 at 53.19
4.1%
Planned (10b5-1)
12 Aug 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$143.04K 3,000 at 47.68
4.0%
Planned (10b5-1)
25 Jul 2024
Sold on a plan
$1.03M 19,056 at 53.88
14.6%
Planned (10b5-1)
25 Jul 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$160.29K 3,000 at 53.43
3.8%
Planned (10b5-1)
15 Jul 2024
Knight Jeff E. Chief Operating Officer
Sold on a plan
$1.49M 27,000 at 55.00
34.3%
Planned (10b5-1)
15 Jul 2024
Sold on a plan
$1.38M 25,000 at 55.00
18.4%
Planned (10b5-1)
10 Jul 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$145.65K 3,000 at 48.55
3.7%
Planned (10b5-1)
5 Jul 2024
Hassard James Chief Commercial Officer
Sold on a plan
$661.20K 15,000 at 44.08
33.9%
Planned (10b5-1)
3 Jul 2024
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$645.01K 14,375 at 44.87
33.5%
Planned (10b5-1)
28 Jun 2024
Sold on a plan
$1.40M 32,129 at 43.61
22.4%
Planned (10b5-1)
26 Jun 2024
Knight Jeff E. Chief Operating Officer
Sold on a plan
$42.43K 956 at 44.38
1.8%
Planned (10b5-1)
25 Jun 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$136.11K 3,000 at 45.37
3.6%
Planned (10b5-1)
24 Jun 2024
Pizzuti Dana Chief Med and Dev Officer
Sold at will
$434.44K 9,500 at 45.73
25.5%
Not planned
21 Jun 2024
Hassard James Chief Commercial Officer
Sold on a plan
$669.90K 15,000 at 44.66
33.9%
Planned (10b5-1)
10 Jun 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$131.58K 3,000 at 43.86
3.5%
Planned (10b5-1)
28 May 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$142.47K 3,000 at 47.49
3.3%
Planned (10b5-1)
10 May 2024
Betz Stephen F. Chief Scientific Officer
Sold on a plan
$148.29K 3,000 at 49.43
3.2%
Planned (10b5-1)
8 May 2024
Struthers Richard Scott President & CEO
Sold on a plan
$5.31M 107,448 at 49.40
29.4%
Planned (10b5-1)
15 Apr 2024
Pizzuti Dana Chief Med and Dev Officer
Sold on a plan
$639.26K 14,375 at 44.47
34.1%
Planned (10b5-1)
4 Apr 2024
Struthers Richard Scott President & CEO
Sold on a plan
$2.01M 40,951 at 49.17
14.7%
Planned (10b5-1)
Showing 1–50 of 150. Page 1 of 3 Older →